December 16, 2017

Biotechnology, Life Sciences, Food and Drug Law News

The National Law Review features a wide variety of content on issues important to life sciences companies, including biosimilars, biotechnology, medical devices, drug pricing, nanotechnology, and pharmaceuticals.  Our content reviews the impact the latest legal changes have on these industries, such as the 21st Century Cures Act. With all of these areas, our content covers issues such as licensing and patents, intellectual property, due diligence, litigation and tax implications.

We also have legal expertise on marketing compliance, licensing and collaborations, and bringing new products to market.  Additionally, the National Law Review is a source for all the latest legal news and regulatory compliance issues involving food and cosmetics safety and labeling requirements, activities of the Food and Drug Administration (“FDA”) and the US Department of Agriculture (“USDA”).

Date Title Organization
15
Dec
FDA Will Publish Draft Guidance on Drug Products, Including Biological Products, that Contain Nanomaterials Bergeson & Campbell, P.C.
15
Dec
EPA to Initiate Proposed Rulemakings to Revise WPS and the C&T Rule Bergeson & Campbell, P.C.
15
Dec
Canadian Reporting Issuers with U.S.-Related Cannabis Activities Dickinson Wright PLLC
15
Dec
IFSAC Releases New Report on Foodborne Illness Source Attribution Estimate for 2013 Keller and Heckman LLP
15
Dec
Digital Health Checkup (Bonus): Product Liability and Insurance Coverage Covington & Burling LLP
15
Dec
Agencies Seek Public Comment On Extension Of ICR On Biobased Procurements Data Bergeson & Campbell, P.C.
15
Dec
EPA Seeks Comment On ICR On RFS Program Bergeson & Campbell, P.C.
15
Dec
AkzoNobel, Bio-on Announce Continued Collaboration On Biobased Coatings Bergeson & Campbell, P.C.
14
Dec
ABA PCRRTK Committee and ELI to Collaborate on Law, Regulation, and Policy of Cannabis Project Bergeson & Campbell, P.C.
14
Dec
Cannabizfile Comes To California Allen Matkins Leck Gamble Mallory & Natsis LLP
14
Dec
EPA’s Approaches for Prioritization under TSCA Discussed at December 11, 2017, Public Meeting Bergeson & Campbell, P.C.
14
Dec
FDA: Antibiotics Sold and Distributed for Use in Food-Producing Animals Down in 2016 Keller and Heckman LLP
13
Dec
Jury Verdict Overturned in Pepcid® Dispute After Court Finds Insufficient Evidence of Infringement Proskauer Rose LLP
13
Dec
Marginal Gains in the NBA: Veganism – A new lease of life for athletes? Squire Patton Boggs (US) LLP
13
Dec
FDA Discontinues Food Advisory Committee Keller and Heckman LLP
13
Dec
Ninth Circuit Will Review Two of Three TSCA Framework Rules Bergeson & Campbell, P.C.
13
Dec
Evidence of Secondary Considerations Could Not Overcome the Weight of the Competing Evidence of Obviousness Andrews Kurth Kenyon
13
Dec
ISO Publishes Standard on Aquatic Toxicity Assessment of Manufactured Nanomaterials in Saltwater Lakes Bergeson & Campbell, P.C.
12
Dec
FDA Issues Fourth and Final Software as a Medical Device Clinical Evaluation Guidance McDermott Will & Emery
12
Dec
Smartwatch News: Privacy Edition Drinker Biddle & Reath LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS